Log In
BCIQ
Print this Print this
 

teprotumumab (RV001) (formerly R1507, RG1507)

  Manage Alerts
Collapse Summary General Information
Company River Vision Development Corp.
DescriptionHumnan mAb targeting the insulin-like growth factor-1 (IGF-1) receptor (IGF1R)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today